Abstract Despite the benefits associated with longer buprenorphine treatment duration (i.e., >180 days) (BTD) for opioid use disorder (OUD), retention…
Abstract Animal models indicate that the endocannabinoid system (ECS) plays a modulatory role in stress and reward processing, both crucially…
Abstract Earlier age of cannabis usage poses higher risk of Cannabis Use Disorder and adverse consequences, such as addiction, anxiety,…
Abstract Objectives: According to the national mental health survey, substance use disorders (SUDs) are prevalent in 22.4% of the population…
Abstract Introduction: Attention-deficit/hyperactivity disorder (ADHD) was originally treated as a neurodevelopmental disorder that occurs mainly in children and tends to…
Abstract Objective: The drug poisoning crisis throughout North America necessitates novel harm reduction approaches. Emerging evidence suggests that cannabidiol (CBD)…
Abstract Background: As a common digestive disorder, choledocholithiasis can have serious consequences, including death. Given that opioids have been shown…
Abstract Rates of return to use in addiction treatment remain high. We argue that the development of improved treatment options…
Abstract Objectives: People with substance use disorders (SUD) are suggested to have higher risk of hospitalization, intubation, or death from…
Abstract Dopamine receptor D2 (DRD2) and ankyrin repeat and kinase domain‐containing protein 1 (ANKK1) genes have received considerable attention for…